AC IMMUNE SA SF-02 (IMR) — Capital Reinvestment Ratio
Latest as of December 2024:
0.02x
AC IMMUNE SA SF-02 (IMR) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow (€5.93 Million) in capital expenditures (€90.00K). See IMR free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
€5.93 Million
EUR
Capital Expenditures
€90.00K
EUR
Data as of
Dec 2024
Most recent filing
AC IMMUNE SA SF-02 Capital Reinvestment Ratio (2024–2024)
This chart tracks AC IMMUNE SA SF-02's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for AC IMMUNE SA SF-02 (2024–2024)
Year-by-year Capital Reinvestment Ratio for AC IMMUNE SA SF-02 from 2024 to 2024. For live market cap and broader valuation context, see AC IMMUNE SA SF-02 market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | €65.84 Million | €576.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow